GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
St. Jude Medical, Inc. (STJ) [hlAlert]

Rating:
Outperform
STJ
up 48.66 %

St. Jude Medical, Inc. (STJ) rated Outperform with price target $53 by Morgan Keegan

Posted on: Wednesday,  Aug 24, 2011  8:25 AM ET by Morgan Keegan

Morgan Keegan rated Outperform St. Jude Medical, Inc. (NYSE: STJ) on 08/24/2011. Previously Morgan Keegan rated Outperform St. Jude Medical, Inc. (NYSE: STJ)
on 06/17/2011., when the stock price was $48.72. Since then, St. Jude Medical, Inc. has gained 48.67% as of 01/28/2016's recent price of $72.43.
If you would have followed the previous Morgan Keegan's recommendation on STJ, you would have gained 48.66% of your investment in 1686 days.

St. Jude Medical, Inc. (St. Jude)develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and implantable neurostimulation devices for the management of chronic pain. The Company operates in four business segments: Cardiac Rhythm Management (CRM), Cardiovascular (CV), Atrial Fibrillation (AF) and Neuromodulation Systems (Neuro). On July 3, 2008, the Company completed the acquisition of EP MedSystems, Inc. On December 19, 2008, St. Jude acquired Radi Medical Systems. On December 22, 2008, St. Jude acquired MediGuide Inc.

Since Morgan Keegan's founding 38 years ago, quality investment research has been a hallmark of the firm. Over the years, we have built our reputation by focusing on companies that have gone unnoticed by Wall Street. Today, our staff of senior equity analysts tracks more than 250 companies concentrated in ten industry sectors
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/24/2011 8:25 AM Buy
None
43.42 53.00
as of 12/30/2011
1 Week down  -1.57 %
1 Month down  -10.77 %
3 Months down  -5.22 %
1 YTD down  -21.00 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/17/2011 8:25 AM Buy
None
48.72 60.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy